INTRODUCTION
Ischaemic changes associated with umbilical arterial cannulation is an important cause of neonatal morbidity in extremely lowbirth-weight and low-birth-weight infants in the Neonatal Intensive Care Unit and occurs in up to 18% of babies with indwelling arterial lines. 1 Topical nitroglycerine in neonates has been shown to be useful in preventing permanent ischaemic changes with tissue loss due to ischaemia from peripheral arterial cannulation and extravasation of inotropes. 2, 3 Topical nitroglycerine is also effective in purpura fulminans for pain relief and reperfusion of ischaemic areas. 4, 5 We report successful use of topical nitroglycerine in an infant with ischaemic changes over the right buttock following insertion of an umbilical arterial catheter. To our knowledge, this is the first report of successful use of topical nitroglycerine in ischaemia following the use of an umbilical arterial catheter.
CASE REPORT
A white male infant was born at an assessed gestational age of 33 weeks to a 19-year-old gravida 2, para 2 woman following spontaneous onset of labor at a peripheral hospital. Birth weight was 1870 g with Apgar scores of 8 and 5 at 1 and 5 minutes, respectively. The baby developed respiratory distress needing ventilatory support and was transported to our Neonatal Intensive Care Unit. On transport, at 4 hours of age, he was saturating >90% in 35% oxygen. He was well perfused with a respiratory rate of 50, mild grunting, and minimal chest recession.
At 10 hours of age, he needed mechanical ventilation and surfactant therapy because of worsening respiratory distress. Ventilation was provided by time-cycled, pressure-limited, continuous flow neonatal ventilator (Infant Star 500; Infrasonics Inc., San Diego) with initial mean airway pressure of 11 cm H 2 O in 90% oxygen. A size 3.5 Fr umbilical arterial catheter was inserted and X-rays confirmed satisfactory positioning in the thoracic aorta at T10. A size 5 Fr umbilical venous catheter was also inserted and positioned above the diaphragm. Morphine infusion (10 g/kg per hour) was commenced to facilitate ventilation. He received dobutamine infusion (10 g/kg per minute) for maintenance of blood pressure. Heparinized saline was infused through the arterial line (rate of 1 ml/hr-1 unit heparin/ml). Four hours after insertion of the arterial line, ischaemic changes measuring 4.5-cm diameter were noted over the right hip ( Figure 1 ). Femoral and popliteal pulses were normally felt. Thrombosis of the gluteal vessels was suspected and the arterial line was removed. The ischaemic changes did not improve and 4 hours later, a 2% nitroglycerine patch was applied as a thin film over the affected area in a dose of 0.4 mg over 2 hours. During Case Report
this time, the mean blood pressure dropped from 33 to 29 mm Hg and responded to adjustments in dobutamine infusion. Over the next 7 hours, skin color improved and the affected skin area reduced. However, as the area affected remained blue, another nitroglycerine patch was reapplied. The rate of dobutamine was again increased to maintain blood pressure.
Resolution of the ischaemic changes was complete by 30 hours after the initial onset of ischaemia. No further topical nitroglycerine therapy was required and the baby was discharged home well on day 44. Ultrasound scans of the brain were normal. At discharge, there was no evidence of any residual damage ( Figure 2 ).
DISCUSSION
Arterial catheterization by umbilical or peripheral route, a common procedure in the Neonatal Intensive Care Unit, is associated with a risk of ischaemia from thrombosis, embolism or vasospasm. 1, 2, 6 Limb shortening and deformity are potential longterm complications. 7 Vasospasm in case of umbilical arterial catheters may compromise blood flow to the kidneys, intestines, buttocks, and lower limbs. 6 It is important to confirm the position of the tip of umbilical arterial lines and to monitor for ischaemic changes (either pallor or purpura) in the lower limbs. 6 The management of ischaemic complications associated with arterial lines includes immediate removal of the catheter, warming of the opposite limb, 6 and the possible role of other drugs 11 such as urokinase, streptokinase, heparin, topical hyaluronidase ointment, and tissue plasminogen activator. 12 Thrombolytic therapy is associated with significant complications including bleeding tendency and risk of microembolization from disintegration of pre-existing clot. 11 Several authors have reported the effectiveness of topical nitroglycerine to increase perfusion to ischaemic areas in children with purpura fulminans. 4 , 5 Denkler and Cohen 3 reported the successful use of topical nitroglycerine in neonates following extravasation of dopamine. Wong et al. 2 reported the safe and convenient use of nitroglycerine to improve capillary flow to ischaemic tissues in neonates with complications following the use of peripheral arterial catheters and vasopressor agents. The authors reported that nitroglycerine is probably safer than other treatment modalities involving the use of streptokinase, urokinase, phentolamine, heparin or hyaluronidase. Analgesic effects of nitroglycerine during treatment of patients with ischaemia have also been described. 4 The dominant action of nitroglycerine is as a nitric oxide donor, causing direct effect on vascular smooth muscle producing vasodilatation of veins and arteries. 8 -10 Nitroglycerine is well absorbed with topical use and the medication is available in various forms. 8 -10 Increased blood flow due to nitroglycerine application may be due to direct arterial and venous dilatation overcoming vasospasm and allowing flow around microthrombi or opening up of collateral circulation to the affected areas. 2, 8 Indeed, topical nitroglycerine has been shown to induce venous dilatation to facilitate venous cannulation in adults 13 and children.
14 Common adverse effects of nitroglycerine include headache and dizziness in adults although serious side effects are rare. 8 -10 Tachycardia and hypotension are other important side effects, but limited data suggest that these complications have been rare among neonatal and pediatric populations. 15 excluded all infants with history of hypotension, vasopressor use, sepsis, severe anemia, coagulation disorders, renal failure, seizures, persistent pulmonary hypertension, and structural heart disease. Wong et al. 2 reported mild degrees of hypotension in two of four cases, but the authors suggested that other factors in hemodynamically unstable babies might have been responsible.
In our case, we observed an improvement within 30 hours of nitroglycerine application to the affected areas. Repeated dosing was required. Our baby had a decrease in mean blood pressure, which responded to adjustments in inotrope support. It is possible that our baby developed ischaemic complications due to the severity of respiratory distress syndrome and associated hypotension. Another cause of ischaemic changes to the gluteal region in sick neonates is the use of alcohol skin preparation for the umbilical cannulation; 17 this is unlikely in our case as we did not use alcohol preparations and the area affected was more lateral and over the hip joint. It is possible that topical application of nitroglycerine is effective in premature babies because of increased permeability of the immature skin especially during the first 5 days of life. 18 Vaksmann et al. 14 found the greatest effect with topical nitroglycerine in young infants, although the response observed in his series might have been related to the use of a higher dose of nitroglycerine. This is the first reported case of the efficacy of nitroglycerine topical application for cutaneous ischaemic changes due to umbilical arterial lines. It is possible that nitroglycerine application could be effective in cases where the ischaemia involves only the skin and not deep and bigger blood vessels. In the latter case, thrombolysis therapy 10 or surgical removal may be indicated. 16 Our experience shows that use of 2% nitroglycerine in a dose of 2 mg/kg may be a safe and effective treatment of cutaneous ischaemia/necrosis associated with umbilical arterial lines. It is important to monitor and promptly manage hypotension, particularly in babies on inotrope support.
